Switzerland is a pharmaceutical giant ... a producer could simply exit the Swiss market. That's why pharmaceutical companies have long demanded that they be compensated for their compulsory ...

This focus on innovation is particularly evident in the tech and pharmaceutical industries ... we'll explore the key reasons to live in Switzerland, the practicalities of moving there-including the ...

So, as the Fed eases, there will be other banks. Already five-six banks have been ahead of the Fed, especially Canada and ECB ...

Even with these fears allayed, why should every pharmaceutical marketer understand ... is a ZS Business Consultant based in Zurich, Switzerland, and is specialised in digital and social media ...

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

But hang on a minute, why on earth should Switzerland, which never joined ... industry has developed very strongly," he says. "Also in pharmaceuticals, the chemical industry is really top notch ...

Why pharma stocks can be more volatile ... phase 1 clinical trial with MDMA and LSD in the fourth quarter in Basel, Switzerland. Meanwhile, Compass Pathways is developing a synthetic version ...

For the second trading session in less than a week, Roche Holding ( RHHBY 3.83%) stock really took it on the chin Wednesday.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Tactics used to persuade U.S. doctors that potent painkillers could be safely prescribed have been used abroad, an ...

Price controls will deprive the pharmaceutical industry of revenue that could be invested in research and development. But the caps will also dissuade investors from funding drug discovery.

Aurinia Pharma's LUPKYNIS is well-positioned to become a new standard of care. Read why I think AUPH stock is a strong buy.